Source: AZoSensors

OpSens: OpSens signs definitive agreement for its acquisition by Haemonetics

Québec City, October 10, 2023 - OpSens Inc. ("OpSens" or the "Corporation") (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering...

Read full article »
Annual Revenue
$25-100M
Employees
250-500
Louis Laflamme's photo - President & CEO of OpSens

President & CEO

Louis Laflamme

CEO Approval Rating

77/100

Read more